Hi Guest Login
Home > Tests > Leiden Mutation Factor V (L) > Gurgaon
₹6650 ₹5320
Report Time
2 DaysFREE
Home Sample Collection
Age Group
Parameters Included
1
Recomended for
Both
Fasting
No Fasting Required
Report Time
2 Days
Exclusive Offer
₹5320
₹6650
FREE Home Sample Collection*
FREE Smart Report
Get a callback from our Health advisor.
Understanding the Test
Test Measures
City Price Info
The Factor V Leiden Mutational Analysis Test is a specialized genetic test that detects a mutation in the Factor V gene, the most common inherited cause of abnormal blood clotting (thrombophilia). For residents of Gurgaon, this test is readily accessible through convenient home sample collection services, allowing accurate assessment of inherited clotting risk without a hospital visit. The Factor V Leiden mutation makes the blood clotting factor resistant to normal regulation, significantly increasing the risk of developing dangerous clots such as deep vein thrombosis (DVT), pulmonary embolism, or complications during pregnancy. This test is essential for identifying individuals with an inherited predisposition to clotting, enabling early diagnosis, informed family planning, and proactive measures to reduce the risk of serious thrombotic events.
The Factor V Leiden Mutational Analysis Test measures the presence of a mutation in the Factor V (F5) gene that increases the blood’s tendency to form abnormal clots. It helps identify whether an individual has inherited this genetic variation and assesses their risk of conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other clotting disorders.
The Factor V Leiden Mutational Analysis test is a genetic test that detects the Factor V Leiden mutation (c.1601G>A, p.Arg534Gln) in the F5 gene. This mutation is the most common inherited cause of thrombophilia, a condition that increases the risk of abnormal blood clots.
Factor V is a protein produced by the liver that plays a key role in blood clotting. Normally, activated protein C (APC) inactivates Factor V to prevent clots from growing too large. The Factor V Leiden mutation changes one amino acid at position 506 (arginine to glutamine), making Factor V resistant to APC inactivation. This causes Factor V to remain active longer, leading to excessive clot formation.
The Factor V Leiden mutational analysis is a DNA-based test that directly identifies the specific genetic mutation. This approach offers several advantages:
Genetic testing provides a definitive diagnosis by directly detecting the mutation in the Factor V (F5) gene. Unlike functional clotting tests, it is not influenced by medications, pregnancy, acute illness, or other acquired conditions. This makes it highly reliable for confirming if a patient carries the mutation.
The test distinguishes between individuals with one copy of the mutation (heterozygous) and those with two copies (homozygous). This is clinically important because thrombotic risk varies significantly. Homozygous individuals have a much higher risk of abnormal blood clots than heterozygous carriers.
A key advantage of genetic testing is its accuracy even when patients take anticoagulants like warfarin, heparin, or direct oral anticoagulants. Unlike functional assays, which these drugs may alter, genetic testing reflects the patient’s true genetic status regardless of treatment.
Since the Factor V mutation is inherited, identifying it in one person allows screening of family members who may be at risk. Early detection helps guide preventive strategies, lifestyle changes, and clinical monitoring to reduce future thrombotic events.
This genetic test provides critical information that helps doctors:
The Factor V Leiden mutation itself causes no symptoms. The first indication of the disorder is typically the development of an abnormal blood clot .
Deep vein thrombosis (DVT) usually occurs in the legs when a blood clot forms in a deep vein. It often causes cramping or soreness in the calf or thigh. One leg may swell compared to the other, and the skin can appear red and feel warm. Some people may have no symptoms, and the clot is found only during medical tests.
A pulmonary embolism occurs when a clot from a DVT breaks off and blocks blood flow in the lungs. This is a serious, life-threatening condition. Common signs include sudden shortness of breath, sharp chest pain that worsens with deep breathing, coughing (sometimes with blood), and a fast heartbeat without clear cause. Immediate medical attention is required.
Sometimes, blood clots form in less common parts of the body. These include veins in the brain, causing severe headaches, seizures, or weakness; veins just under the skin, appearing as painful, red cords; veins in the abdomen affecting the liver or intestines; and veins in the eye, which can cause sudden vision problems. These unusual clots may be linked to genetic clotting disorders.
Women with clotting disorders like Factor V Leiden may have a higher risk of pregnancy complications. These include repeated miscarriages, stillbirth, early placental separation, high blood pressure during pregnancy (preeclampsia), and slow fetal growth. Proper monitoring and care can help manage these risks.
If close family members, like parents or siblings, have had blood clots—especially at a young age—it may indicate an inherited clotting tendency. Doctors may recommend testing to identify genetic conditions and take preventive steps to reduce future risk.
Testing for Factor V Leiden is not recommended for everyone. Professional guidelines recommend testing in specific clinical scenarios .
If close family members, like parents or siblings, have had blood clots—especially at a young age—it may indicate an inherited clotting tendency. Doctors may recommend testing to identify genetic conditions and take preventive steps to reduce future risk.
People with close relatives who had blood clots, particularly at a young age or repeatedly, may benefit from testing to identify inherited risk.
Women planning oral contraceptives or hormone therapy should consider testing if they have a personal or family history of clots, since estrogen increases clot risk.
Testing may be useful in women with recurrent pregnancy loss, stillbirth, preeclampsia, or poor fetal growth, where clotting disorders may play a role.
In patients with unprovoked clots, testing may be considered before stopping blood thinners, although its benefit is debated.
Testing relatives is optional and should depend on individual risk and counseling, especially for high-risk situations like surgery or pregnancy.
Testing is not recommended for clots caused by major triggers, arterial conditions like heart attack or stroke, or in people without symptoms or family history.
The following table provides a quick overview of the key details of the Factor V Leiden test.
|
Parameter |
Details |
|
Test Name |
Factor V Leiden Mutational Analysis |
|
Also Known As |
Factor V Leiden Mutation, F5 Gene Mutation Analysis, APC Resistance Genetic Test |
|
Sample Type |
EDTA tube |
|
Gender |
Both |
|
Age Group |
All |
|
Fasting Required |
No |
|
Report Time |
2 Days |
|
Home Collection |
Available |
Preparing for this genetic test is straightforward.
The Factor V Leiden test is DNA-based and usually not affected by medications or body conditions. However, sample quality, handling, and lab methods can impact the accuracy or success of the test.
Anticoagulant medicines like warfarin, heparin, or DOACs do not affect this test because it is based on DNA. The result remains accurate regardless of ongoing treatment.
Pregnancy does not change the genetic result, as DNA remains constant. Therefore, testing during pregnancy is reliable.
Poor sample quality, such as hemolysis (damaged blood cells), contamination, or low sample volume, can lead to test failure or inaccurate results.
If the sample is not handled properly, especially if plasma is separated incorrectly before transport, it may become unsuitable for testing and get rejected.
Different PCR-based methods may be used, but all validated techniques are highly accurate. Minor differences in sensitivity may exist between labs, but results are generally reliable.
Results are reported as the specific genotype detected. Interpretation should always be done by a hematologist or genetic counselor in the context of clinical symptoms and family history .
|
Result |
Genotype |
Interpretation |
Clinical Implications |
|
Not Detected |
Normal (GG) |
No Factor V Leiden mutation present |
No increased risk from Factor V Leiden; other causes of thrombosis should be considered |
|
Heterozygous |
One copy (GA) |
Mildly increased thrombotic risk |
5 to 10-fold increased risk of VTE compared to non-carriers; annual VTE risk ~0.5% |
|
Homozygous |
Two copies (AA) |
Significantly increased thrombotic risk |
50 to 100-fold increased risk of VTE compared to non-carriers; much higher baseline risk |
Although Factor V Leiden increases relative risk, most individuals—especially heterozygotes never develop a blood clot. The overall (absolute) risk remains low.
Clot risk increases when combined with other factors such as additional genetic mutations (e.g., Prothrombin G20210A), obesity, smoking, use of oral contraceptives, pregnancy, or prolonged immobility.
Once identified in a patient, family members may consider testing after genetic counseling. Each child of a heterozygous parent has a 50% chance of inheriting the mutation.
Factor V Leiden mainly increases the risk of venous clots like DVT and pulmonary embolism, and is not a common cause of heart attacks or strokes.
Sample collection is carried out by highly trained professionals who follow strict protocols to ensure accuracy and safety in genetic testing.
All samples are processed in NABL-accredited laboratories using validated real-time PCR techniques for reliable mutation detection.
Proper sample handling is ensured, including controlled transport conditions and prevention of improper processing, which is critical for accurate DNA analysis.
Book your test at a time that suits you, with hassle-free doorstep sample collection—no need to visit a hospital or lab.
From easy booking to timely report delivery, MAX@Home offers complete assistance at every step of your testing journey.
Early identification of Factor V Leiden can guide preventive measures during high-risk situations such as surgery, pregnancy, or prolonged travel. Do not ignore a family history of blood clots or unexplained thrombotic events.
Read More
You've selected items to compare.
View All
MAX@Home is one of Gurgaon’s leading providers of diagnostic services, with lab-test centres located across all major localities in the city.